CoreWeave (NASDAQ:CRWV)'s $9 billion all-stock acquisition of data center operator Core Scientific (NASDAQ:CORZ) is facing shareholder resistance, with major investors saying they may vote against the deal unless its terms are updated, according to a Financial Times report. The FT, citing people familiar with the matter, said the pushback stems from concerns that the current offer undervalues Core Scientific and exposes its investors to unnecessary downside risk.

MAR's second-quarter results reflect strong travel demand and expansion momentum despite macro uncertainty.

AGNC's Q2 book value per share slid 7% as widening mortgage spreads and MBS losses pressured portfolio valuations.

Block & Leviton reminds investors that a securities fraud lawsuit has been filed against Replimune Group (Nasdaq: REPL). Investors should contact the firm.

MILWAUKEE , Aug. 5, 2025 /PRNewswire/ -- The Ademi Firm is investigating Y-mAbs (NASDAQ: YMAB) for possible breaches of fiduciary duty and other violations of law in its transaction with SERB Pharmaceuticals. Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995.

Tesla Inc (NASDAQ:TSLA) and its CEO Elon Musk were sued by shareholders who accused the electric vehicle maker of securities fraud for allegedly concealing safety risks associated with its self-driving vehicles, including the recently tested Robotaxi. The proposed class action, filed late Monday in federal court in Austin, Texas, claims Tesla misled investors by overstating the capabilities of its autonomous driving technology and failing to disclose operational flaws that could compromise safety and violate traffic laws.

Palantir Technologies Inc. delivered a blowout quarter, surpassing $1B in revenue months ahead of schedule, and America's defense spend (and commercial spend) is to thank. We don't think Palantir is going anywhere; it's safe to say they've carved a sticky place for themselves at the intersection of AI, data analytics, and defense. U.S. revenue, about 73% of total sales, is on a bullet train, but the international side of the business is what we think will drive the stock that extra mile.

Carvana's promising performance metrics highlight its ongoing reversal from prior pandemic pains, as they competently monetize the used car inventories and in-house loan sales. These reasons may also be why the management has felt confident to offer robust FY 2025 adj. EBITDA guidance, with the cash flows already flowing into its healthier balance sheet. With used cars cheaper than new cars, we believe that CVNA may continue to outperform in the near term for so long that demand remains healthy.

EXPE eyes Q2 revenue growth despite U.S. softness, with B2B strength and cost cuts driving profit margin gains.

Pre-market futures are in the green across major indexes this morning, but experiencing a bit of choppiness. The Dow and S&P 500 are both up mere single-digits at this hour, off the early-morning highs, while the tech-heavy Nasdaq stays up +70 points presently.

Morning Brief anchor Julie Hyman breaks down the latest market news for Aug. 5, 2025. Palantir stock jumps after reporting a 48% increase in quarterly revenue.

Broadridge Financial Solutions, Inc. (NYSE:BR ) Q4 2025 Earnings Conference Call August 5, 2025 8:30 AM ET Company Participants Ashima Ghei - Corporate VP & Chief Finance Officer Timothy C. Gokey - CEO & Director W.

WALWORTH, Wis.--(BUSINESS WIRE)--Maintained, repaired and refinished, but never restored, Bianco Speciale, the only Ferrari 250 GTO to leave the Ferrari factory in white, is set to headline the Mecum Auctions lineup at The World's Largest Collector Car Auction® this January in Kissimmee, Florida. Among the mere 36 produced from 1962 to 1964, Bianco Speciale stands alone as the sole 250 GTO delivered with an unprecedented white livery applied by the Ferrari factory. This distinguishes it as one.

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Marex Group PLC (Nasdaq: MRX) for potential securities law violations. Investors who have lost money in their Marex Group investment should contact the firm to learn more about how they might recover those losses.

Addus HomeCare Corporation (NASDAQ:ADUS ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants Brian W. Poff - CFO, Executive VP, Secretary & Treasurer R.

TTWO aims for revenue growth in fiscal Q1, driven by NBA 2K and Zynga, but higher expenses and GTA softness are likely to have impacted earnings.

The headline numbers for Organon (OGN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

The headline numbers for Hamilton Lane (HLNE) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

The headline numbers for Palantir Technologies (PLTR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Michael Cherny sees opportunity for Hims & Hers (HIMS), as long as it can overcome headwinds facing its non-weight loss businesses. He argues the stock hasn't traded on fundamentals and weighs heavily on its GLP-1 drugs sales.